Mesoblast asks for trad­ing halt as PDU­FA date slides by. What's up?

Every­thing was all lined up for Mesoblast’s Wednes­day PDU­FA date re­gard­ing its acute graft-ver­sus-host dis­ease can­di­date remestem­cel-L, or Ry­on­cil. But with no word in any …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER